The Net Margin of Enanta Pharmaceuticals Inc (ENTA) is
-125.36%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2025-09-30 |
-125.36%
|
| 2024-09-30 |
-171.58%
|
| 2023-09-30 |
-168.94%
|
| 2022-09-30 |
-141.30%
|
| 2021-09-30 |
-81.36%
|
| 2020-09-30 |
-29.55%
|
| 2019-09-30 |
22.61%
|
| 2018-09-30 |
34.85%
|
| 2017-09-30 |
17.22%
|
| 2016-09-30 |
24.58%
|
| Ticker |
Name |
Value |
|
RCEL
|
AVITA Medical Inc
|
-67.85%
|
|
RNA
|
Atrium Therapeutics Inc
|
-265.88%
|
|
STRO
|
Sutro Biopharma Inc
|
-186.45%
|
|
TH.TO
|
Theratechnologies Inc
|
-9.67%
|
|
AMGN
|
Amgen Inc
|
20.98%
|
|
AQB
|
AquaBounty Technologies Inc
|
-1132.38%
|
|
MNKD
|
MannKind Corporation
|
1.68%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
31.41%
|
|
ANIK
|
Anika Therapeutics Inc
|
-9.64%
|
|
HRTX
|
Heron Therapeutics Inc
|
-13.04%
|
|
MDXG
|
MiMedx Group, Inc.
|
11.60%
|
|
ONPH
|
Oncology Pharma Inc
|
-1822.14%
|
|
PGEN
|
Precigen, Inc.
|
-2588.21%
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
-4612.13%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
-3733.25%
|
|
ADAG
|
Adagene Inc.
|
-229.56%
|
|
ALT
|
Altimmune, Inc.
|
-214860.99%
|
|
EGRX
|
Eagle Pharmaceuticals Inc
|
11.24%
|
|
GILD
|
Gilead Sciences, Inc.
|
28.90%
|
|
KDMN
|
Kadmon Holdings Inc
|
-1313.75%
|
|
ABBV
|
AbbVie Inc.
|
6.91%
|
|
CPRX
|
Catalyst Pharmaceuticals, Inc.
|
36.39%
|
|
CRIS
|
Curis Inc
|
-80.29%
|
|
CVM
|
CEL-SCI Corp
|
-5415.68%
|
|
FLXN
|
Flexion Therapeutics Inc
|
-132.92%
|
|
HGEN
|
Humanigen Inc
|
-2817.93%
|
|
IMAB
|
I-Mab
|
-752.42%
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
-101.08%
|
|
950200.KQ
|
Psomagen Inc
|
-5.04%
|
|
ATNX
|
Athenex Inc
|
-100.59%
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
-16748.03%
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
-5.63%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
32.94%
|
|
950220.KQ
|
Neoimmunetech Inc
|
-33533.01%
|
|
CDMO
|
Avid Bioservices Inc
|
-100.60%
|
|
MGTX
|
MeiraGTx Holdings PLC
|
-140.31%
|
|
MRNA
|
Moderna, Inc.
|
-145.16%
|